Morning Briefing
Summaries of health policy coverage from major news organizations
Even As Observers Write Its Obituary, Theranos Pushes Expansion Narrative
The bedeviled blood-testing startup has posted 200 job openings and has recently made several higher-level moves as well.
As the ship keeps sinking, Theranos hasn鈥檛 stopped shuffling the deck chairs. The Silicon Valley company that promised to revolutionize blood testing has had so many setbacks lately that it鈥檚 getting hard to keep track. Theranos is under criminal and civil investigation. Federal regulators are considering revoking the license of its California lab and banning its chief executive from the industry for two years. Just this week, news broke that it had voided two years of test results from its signature blood-testing devices. (Robbins and Keshavans, 5/19)
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
